Hints and tips:
...Immucor, the biotechnology company, added 30.2 per cent to $26.99 after agreeing to be bought by private equity group TPG Capital for a fully diluted equity value of $1.97bn....
...Pfizer in April agreed to sell its Capsugel business to KKR for $2.4bn, while TPG recently struck a $2bn deal to buy Immucor, a diagnostics company....
International Edition